Megakaryocytes contain extranuclear histones and may be a source of platelet-associated histones during sepsis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 03 2020
Historique:
received: 19 09 2019
accepted: 24 02 2020
entrez: 14 3 2020
pubmed: 14 3 2020
medline: 24 11 2020
Statut: epublish

Résumé

Histones are typically located within the intracellular compartment, and more specifically, within the nucleus. When histones are located within the extracellular compartment, they change roles and become damage-associated molecular patterns (DAMPs), promoting inflammation and coagulation. Patients with sepsis have increased levels of extracellular histones, which have been shown to correlate with poor prognosis and the development of sepsis-related sequelae, such as end-organ damage. Until now, neutrophils were assumed to be the primary source of circulating histones during sepsis. In this paper, we show that megakaryocytes contain extranuclear histones and transfer histones to their platelet progeny. Upon examination of isolated platelets from patients with sepsis, we identified that patients with sepsis have increased amounts of platelet-associated histones (PAHs), which appear to be correlated with the type of infection. Taken together, these results suggest that megakaryocytes and platelets may be a source of circulating histones during sepsis and should be further explored.

Identifiants

pubmed: 32165642
doi: 10.1038/s41598-020-61309-3
pii: 10.1038/s41598-020-61309-3
pmc: PMC7067782
doi:

Substances chimiques

Biomarkers 0
Histones 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4621

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM092804
Pays : United States

Références

Venkatesh, S. & Workman, J. L. Histone exchange, chromatin structure and the regulation of transcription. Nat. Rev. Mol. Cell Biol. 16, 178–179 (2015).
pubmed: 25650798 doi: 10.1038/nrm3941 pmcid: 25650798
Chen, R., Kang, R., Fan, X.-G. et al. Release and activity of histone in diseases. Cell Death & Disease. 5, e1370 (2014).
doi: 10.1038/cddis.2014.337
Parseghian, M. H. & Luhrs, K. A. Beyond the walls of the nucleus: the role of histones in cellular signaling and innate immunity. Biochem. Cell Biol. 84, 589–604 (2006).
pubmed: 16936831 doi: 10.1139/o06-082 pmcid: 16936831
Xu, Z. et al. Sepsis and ARDS: the dark side of histones. Mediators Inflammation. 2015, 205054 (2015).
Miki, T. & Iba, T. Kinetics of circulating damage-associated molecular patterns in sepsis. J. Immunol. Research. 2015, 424575 (2015).
doi: 10.1155/2015/424575
Li, Y. et al. Identification of Cit H3 as a potential serum protein biomarker in a lethal model of LPS-induced shock. Surgery. 150(3), 442–451 (2011).
pubmed: 21878229 pmcid: 3170094 doi: 10.1016/j.surg.2011.07.003
Chaput, C. & Zychlinsky, A. Sepsis: the dark side of histones. Nat. Medicine. 15, 1245–1246 (2009).
doi: 10.1038/nm1109-1245
Jansen, M. P. B. et al. Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. Kidney International. 91(2), 352–364 (2017).
pubmed: 27692564 doi: 10.1016/j.kint.2016.08.006 pmcid: 27692564
Kalbitz, M. et al. Role of extracellular histones in the cardiomyopathy of sepsis. FASEB J. 29(5), 2185–2193 (2015).
pubmed: 25681459 pmcid: 4415013 doi: 10.1096/fj.14-268730
Alhamdi, Y. et al. Histone-associated thrombocytopenia in critically ill patients. JAMA. 315(8), 817–819 (2016).
pubmed: 26903341 pmcid: 4817207 doi: 10.1001/jama.2016.0136
Gould, T. J., Lysov, Z. & Liaw, P. C. Extracellular DNA and histones: double-edged swords in immunothrombosis. J. Thromb. Harmost. 13(Suppl 1), S82–91 (2015).
doi: 10.1111/jth.12977
Varju, I. et al. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment. Thromb. Haemost. 113(6), 1289–98 (2015).
pubmed: 25789443 doi: 10.1160/TH14-08-0669 pmcid: 25789443
Bealieu, L. M. & Freedman, J. E. The tole of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes. Thromb. Res. 125(3), 205–209 (2011).
doi: 10.1016/j.thromres.2009.11.004
Kim, S. J. & Jenne, C. N. Role of platelets in neutrophil extracellular trap (NET) production and tissue injury. Semin. Immunol. 28(6), 546–554 (2016).
pubmed: 27876233 doi: 10.1016/j.smim.2016.10.013 pmcid: 27876233
Rossaint, J., Margraf, A. & Zarbock, A. Role of platelets in leukocyte recruitment and resolution of inflammation. Front. Immunol. 9, 2712 (2018).
pubmed: 30515177 pmcid: 6255980 doi: 10.3389/fimmu.2018.02712
Semple, J. W., Italiano, J. E. & Freedman, J. Platelets and the immune continuum. Nat. Rev. Immunol. 11(4), 264–274 (2011).
pubmed: 21436837 doi: 10.1038/nri2956 pmcid: 21436837
Clark, S. R. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13(4), 463–469 (2007).
pubmed: 17384648 doi: 10.1038/nm1565 pmcid: 17384648
Zucoloto, A. Z. & Jenne, C. N. Platelet-neutrophil interplay: Insights into neutrophil extracellular trap (NET)-driven coagulation and infection. Front. Cardiovasc. Med. 6, 85 (2019).
pubmed: 31281822 pmcid: 6595231 doi: 10.3389/fcvm.2019.00085
Frydman, G. H. The Role of Megakaryocytes and Platelets in Infection and Immunothrombosis. Thesis: Sc.D., Massachusetts Institute of Technology, Dept of Biological Engineering (2018).
Dunn, K. L. & Davie, J. R. Stimulation of the Ras-MAPK pathway leads to independent phosphorylation of histone H3 on serine 10 and 28. Oncogene. 24, 3492–3502 (2005).
pubmed: 15735677 doi: 10.1038/sj.onc.1208521 pmcid: 15735677
Gabler, C. et al. Extranuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis. Ann. Rheum. Dis. 63, 1135–1144 (2004).
pubmed: 15308524 pmcid: 1755110 doi: 10.1136/ard.2003.011452
Zhao, B. et al. Nuclear condensation during mouse erythropoiesis requires caspase-3-mediated nuclear opening. Dev. Cell. 36(5), 498–510 (2016).
pubmed: 26954545 pmcid: 4785602 doi: 10.1016/j.devcel.2016.02.001
Peterson, J. E. et al. Normal ranges of angiogenesis regulatory proteins in human platelets. Am. J. Hematol. 85(7), 487–493 (2010).
pubmed: 20575035 doi: 10.1002/ajh.21732 pmcid: 20575035
Silk, E. et al. The role of extracellular histone in organ injury. Cell Death Disease. 8(5), e2812 (2017).
pubmed: 28542146 pmcid: 5520745 doi: 10.1038/cddis.2017.52
Russell, R. T. et al. Histone-complexed DNA fragment levels are associated with coagulopathy, endothelial cell damage, and increased mortality after severe pediatric trauma. Shock. 49(1), 44–52 (2017).
doi: 10.1097/SHK.0000000000000902
Semeraro, F. et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 118(7), 1952–1961 (2011).
pubmed: 21673343 pmcid: 3158722 doi: 10.1182/blood-2011-03-343061
Ekaney, M. L. et al. Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit. Care. 18(5), 543 (2014).
pubmed: 25260379 pmcid: 4201918 doi: 10.1186/s13054-014-0543-8
Garcia-Gimenez, J. L. et al. A new mass spectrometry-based method for the quantification of histones in plasma from septic shock patients. Sci. Reports. 7, 10643 (2017).
Kim, J. E. et al. Circulating levels of DNA-histone complex and dsDNA are independent prognostic factors of disseminated intravascular coagulation. Thrombosis Research. 135(6), 1064–1069 (2015).
pubmed: 25843168 doi: 10.1016/j.thromres.2015.03.014 pmcid: 25843168
Kimball, A. S. et al. The emerging role of NETs in venous thrombosis and immunothrombosis. Front. Immunol. 7, 236 (2016).
pubmed: 27446071 pmcid: 4921471 doi: 10.3389/fimmu.2016.00236
Savva, A. & Roger, T. Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front. Immunol. 4, 387 (2013).
pubmed: 24302927 pmcid: 3831162 doi: 10.3389/fimmu.2013.00387
Fenhammer, J. et al. Renal effects of treatment with a TLR4 inhibitor in conscious septic sheep. Crit. Care. 18, 488 (2014).
Ciarlo, E., Savva, A. & Roger, T. Epigenetics in sepsis: targeting histone deacetylases. Int. J. Antimicrob. Agents. 42(Suppl), S8–12 (2013).
pubmed: 23664675 doi: 10.1016/j.ijantimicag.2013.04.004
Takebe, M. et al. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis. J. Surg. Res. 187(2), 559–570 (2014).
pubmed: 24290430 doi: 10.1016/j.jss.2013.10.050
Li, Y. et al. Inhibition of deacetylase 6 improves long-term survival in a lethal septic model. J. Trauma. Acute Care Surg. 78(2), 378–385 (2015).
pubmed: 25757125 pmcid: 4357277 doi: 10.1097/TA.0000000000000510
Li, Y. et al. Citrullinated histone 3 – a novel target for treatment of sepsis. Surgery. 156(2), 229–234 (2014).
pubmed: 24957671 pmcid: 4267527 doi: 10.1016/j.surg.2014.04.009
Gollomp, K. et al. The NET effect: platelet factor 4 and DNA-histone interactions in sepsis. Blood. 126, 2197 (2015).
doi: 10.1182/blood.V126.23.2197.2197
Fuchs, T. A. et al. Novel cell death program leads to neutrophil extracellular traps. JCB. 176(2), 231–241 (2007).
pubmed: 17210947 doi: 10.1083/jcb.200606027
Kile, B. T. The role of apoptosis in megakaryocytes and platelets. BJH 165(2), 217–226 (2014).
pubmed: 24467740 doi: 10.1111/bjh.12757 pmcid: 24467740
Joseffson, E. C. et al. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. JEM. 208(10), 2017 (2011).
doi: 10.1084/jem.20110750
Josefsson, E. C. et al. Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways. Nat. Comm. 5, 3455 (2014).
doi: 10.1038/ncomms4455
Li, J. & Kuter, D. J. The end is just the beginning: megakaryocyte apoptosis and platelet release. Int. J. Hematol. 74(4), 365–374 (2001).
pubmed: 11794690 doi: 10.1007/BF02982078 pmcid: 11794690
Kozuma, Y. et al. Caspase activation is involved in early megakaryocyte differentiation but not in platelet production from megakaryocytes. Leukemia. 23, 1080–1086 (2009).
pubmed: 19212331 doi: 10.1038/leu.2009.7 pmcid: 19212331
Clarke, M. C. H. et al. Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent cell death. JCB. 160(4), 577–587 (2003).
pubmed: 12591916 doi: 10.1083/jcb.200210111 pmcid: 12591916
De Bottom, S. et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood. 100(4), 1310–1317 (2002).
doi: 10.1182/blood-2002-03-0686
Gabler, C. et al. Accumulation of histones in cell lysates precedes expression of apoptosis-related phagocytosis signals in human lymphoblasts. ANNALS. 1010, 221–224 (2003).
Stewart, D. I. H., Golosinska, K. & Smillie, L. B. Identification of a troponin-I like protein in platelet preparations as histone H2B. FEBS. 157(1), 129–132 (1983).
doi: 10.1016/0014-5793(83)81130-2
Vulliamy, P. et al. Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage. PNAS. 116(35), 17444–17449 (2019).
pubmed: 31405966 doi: 10.1073/pnas.1904978116 pmcid: 31405966
Nishimura, S. et al. Ruptured megakaryocytes rapidly release new platelets in response to interleukin-1a. J. Cell Biol. 209, 453–466 (2015).
pubmed: 25963822 pmcid: 4427781 doi: 10.1083/jcb.201410052
Lewandowska, K., Kaplan, D. & Husel, W. CD34 expression on platelets. Platelets. 14(2), 83–87 (2003).
pubmed: 12745450 doi: 10.1080/0953710031000080577 pmcid: 12745450
Hurley, S. M. et al. The dynamics of platelet activation during the progression of streptotoccal sepsis. PLOS One. 11(9), e0163531 (2016).
pubmed: 27656898 pmcid: 5033464 doi: 10.1371/journal.pone.0163531
Layios, N. et al. Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study. Intensive Care Med. Exp. 5(1), 32 (2017).
pubmed: 28699088 pmcid: 5505890 doi: 10.1186/s40635-017-0145-2
Woth, G. et al. Platelet aggregation in severe sepsis. J Thromb Thrombolysis. 31(1), 6–12.
doi: 10.1007/s11239-010-0486-0
Davies, G. R. et al. The role of whole blood impedance aggregommetry and its utilization in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness. PLoS One. 9(9), e108589 (2014).
pubmed: 25269018 pmcid: 4182491 doi: 10.1371/journal.pone.0108589
Grozovsky, R., Hoffmeister, K. M. & Falet, H. Novel clearance mechanisms of platelets. Curr. Opin. Hematol. 17(6), 585–589 (2010).
pubmed: 20729731 pmcid: 4303238 doi: 10.1097/MOH.0b013e32833e7561
Ma, R. et al. Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis. Sci. Rep. 7, 4978 (2017).
pubmed: 28694452 pmcid: 5504060 doi: 10.1038/s41598-017-04773-8
Rondina, M. T. et al. Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J. Gerontology. 70(2), 225–231 (2015).

Auteurs

Galit H Frydman (GH)

Division of Comparative Medicine and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America. gfrydman@mit.edu.
BioMEMS Resource Center, Center for Engineering in Medicine, and Center for Surgery, Innovation and Bioengineering, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States of America. gfrydman@mit.edu.

Shannon N Tessier (SN)

BioMEMS Resource Center, Center for Engineering in Medicine, and Center for Surgery, Innovation and Bioengineering, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

Keith H K Wong (KHK)

BioMEMS Resource Center, Center for Engineering in Medicine, and Center for Surgery, Innovation and Bioengineering, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

Charles R Vanderburg (CR)

Harvard Neurodiscovery Center, Harvard Medical School, Boston, Massachusetts, United States of America.

James G Fox (JG)

Division of Comparative Medicine and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.

Mehmet Toner (M)

BioMEMS Resource Center, Center for Engineering in Medicine, and Center for Surgery, Innovation and Bioengineering, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

Ronald G Tompkins (RG)

BioMEMS Resource Center, Center for Engineering in Medicine, and Center for Surgery, Innovation and Bioengineering, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

Daniel Irimia (D)

BioMEMS Resource Center, Center for Engineering in Medicine, and Center for Surgery, Innovation and Bioengineering, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States of America. dirimia@hms.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH